Insiders who reported open-market trades in the last 12 months at the companies Daniel Patrick O'Day files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Johanna Mercier - $18.17M in GILD purchases and sales in the last 12 months
Deborah H. Telman - $6.59M in GILD purchases and sales in the last 12 months
Andrew D. Dickinson - $4.38M in GILD purchases and sales in the last 12 months
Anthony Welters - $2.68M in GILD purchases and sales in the last 12 months
Jeffrey Bluestone - $1.35M in GILD purchases and sales in the last 12 months
Kelly A. Kramer - $713K in GILD purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Daniel Patrick O'Day is a corporate insider, tracked as Chairman & CEO, Director of GILEAD SCIENCES, INC. (GILD). InsiderAlpha holds 23 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Daniel Patrick O'Day submitted recently?
4 primary Form 4 filings in the last 90 days, covering 1 company.
Has Daniel Patrick O'Day been buying or selling stock?
Recorded transactions: 0 open-market purchases and 34 open-market sales ($55.69M) across all tracked filings.
Daniel Patrick O'Day is Chairman & CEO, Director of GILEAD SCIENCES, INC. (GILD). 23 SEC Form 4 filings on record going back to 2024, most recently on 2 October 2026. Most recent open-market trade: sold $446K of GILD on 2 October 2026. Lifetime open-market sales: $55.69M.
Recent transactions
20
The latest 20 SEC Form 4 transactions reported by Daniel Patrick O'Day.
InsiderAlpha's records for Daniel Patrick O'Day go back to 2024: 23 primary Form 4 filings, an average of 7.7 per year. 32 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
